Ogbonge South Africa celebrity surgeon Dr Pert don die
Dr Pert na ogbonge body surgeon for South Africa wey dey well known for her specialisation for bodi mata.
She be di founder of di Centre for Body Sculpting for Pretoria, South Africa.
Dem announce her death through one statement for her organisation Instagram page wia dem describe am as 'untimely'.
"Na wit great sadness to announce di untimely passing of Dr Pert. We dey heartbroken by dis loss."
Her organisation and family describe her as light wey her legacy go live on.
"She be light to many, and her legacy go live on through di countless lives wey she don touch."
Sake of her death, her organisation don cancel all di appointments wey dem get today.
Dr Pert get strong social influence wia she dey tok about body procedures like flat tummy, BBL and any oda body surgeries.
Dem describe Dr Pert as more dan just a medical doctor, but she don make name for hersef for di world of aesthetic medicine, and one of South Africa leading body sculpting specialists.
According to her organisation, Dr Pert don do ova 100 successful procedures wey she perform on African bodies.
She be di Founder of Dr Pert Centre For Body Sculpting and Dr Pert Recovery House.
Bifor her death, Dr Pert bin dey passionate about celebrating African beauty through science, artistry, and care.
She dey help women do dia body and put am for shape and dose wey wan get curves and beta skin, she dey involved.
For South Africa, Dr Pert dey known for her Brazilian Butt Lift (BBL) procedures wey different medical groups don criticise sake of di mortality rates.
Dem dey use BBLs to make pesin bum-bum to dey bigger, to round well-well or to lift am up too.
Surgeons dey insert silicone-filled implants/or inject fat wey dem collect from oda parts of di body like belly and back to put for di bum-bum to make am big.
Dem born Dr Pert for Hammanskraal, Tshwane and she launch her aesthetic practice for 2017 bifor e grow into wetin pipo including celebrities dey patronise.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
3 hours ago
- Telegraph
ME is a real illness, genetic study shows
A genetic cause for ME has been found for the first time, proving the illness is real. In a breakthrough that charities said finally provided 'credibility and validity' for sufferers, the University of Edinburgh found eight areas of genetic code that make a diagnosis more likely. The gene activity was seen mainly in the nervous and immune systems, suggesting that people with ME may struggle to clear infections and experience ongoing symptoms of pain, fatigue and illness that other people recover from. Sonya Chowdhury, co-investigator on the study and chief executive of Action for ME, said: 'For years, many people have been maligned and disbelieved, and our findings will change this. 'We know that many people have experienced comments like 'ME's not real'. They've been to doctors and told that it's not a real illness. 'Being able to take this study into the treatment room and to say there are genetic causes that play a part in ME is going to be really significant. It will rebuff that lack of belief and stigma that exists.' ME, or myalgic encephalomyelitis – which is often known as chronic fatigue syndrome – is a long-term illness characterised by extreme fatigue that is not relieved by rest, and may bring malaise after exercise, sleep problems, brain fog and chronic pain. About 1.35 million people in Britain are thought to suffer with some kind of ME-like symptoms, which often occur following an infection such as flu, Covid or Epstein-Barr. But the vagueness of the illness and difficulty finding a trigger has often led patients to be treated with scepticism, even by medical professionals. In the past, the condition was regularly dismissed as 'yuppie flu'. For the new study, researchers analysed the DNA of more than 15,000 people participating in DecodeMe – the world's largest database of people with the disease. They found eight regions of DNA where genetic differences were significantly more common in people with ME/chronic fatigue syndrome than in the general population. As a person's DNA does not change over time, experts say the genetic signals likely reflect the causes of the disease. Prof Chris Ponting, DecodeME investigator from the University of Edinburgh, said: 'What we are looking at is genetic variants which tilt the balance one way or another towards or away from the risk of diagnosis of ME in exactly the same way as (genes) do for diabetes or Parkinson's. 'These genetic signals lie very close to genes which are now well known to be involved in the first response to infection, and so it could very well be for some people that an infection via viruses or bacteria are less well cleared with people with ME. 'People with ME often report an infection before their first onset of symptoms. This occurs with the majority of people with ME, so overall the genetics align with what people have described.' Among the genes involved is RABGAP1L, which limits virus replication and expels bacteria, but is less active in patients with ME. Another is FBXL4, which is crucial for keeping mitochondria – the cell batteries – functioning correctly, but is under-expressed in some people with ME. Researchers say the findings are not yet ready to inform treatment or diagnosis, but offer vital clues to the disease's origins and could guide future drug development. Andy Devereux-Cooke, an ME patient who has worked as a co-investigator on the project, said the findings were important for patients who had felt 'abandoned'. 'This will be huge for the patient population,' he said. 'Even though it does not provide all the answers, it is a welcome drop in the ocean towards turning the tide.' The DecodeME team is now calling on researchers from around the world to use the dataset to develop new studies that could lead to new insights and possible treatments. They were reported in a pre-print on Wednesday and are to be submitted for publication in the coming months.
BBC News
6 hours ago
- BBC News
Wolverhampton wins vote to host National Recovery Walk
Wolverhampton has won a public vote to host an event that celebrates people's recovery from year a different place is selected for the National Recovery Walk which includes a public march and a "village" that hosts activities and performances, Wolverhampton City Council annual event will this year be held at West Park on 13 September and will welcome former addicts, their families and council's mayor Craig Collingswood said the initiative provided an opportunity "for people and partners across Wolverhampton" to showcase their commitment to promoting health and wellbeing and supporting those on their recovery journey. The event is endorsed by human rights advocacy case worker service Faces & Voices of Recovery UK, which campaigns for better access and treatment choices for those seeking help with CEO, Anne Marie Ward, said Wolverhampton's "rich culture and strong recovery community" made it the "perfect backdrop for this year's walk".She added: "We come together as individuals in recovery, families, allies and professionals to celebrate lives reclaimed from addiction and to honour the memory of those we have lost."Recovery Walk 2025 promises to be a family-friendly day with live entertainment and community stalls, the council added. Follow BBC Wolverhampton & Black Country on BBC Sounds, Facebook, X and Instagram.
Medical News Today
7 hours ago
- Medical News Today
Free online tool may help calculate biological heart age and disease risk
A person's 'heart age' may not always be the same as their chronological age, which can raise a person's risk for heart disease. A team of researchers has developed a free online tool to help people calculate their heart age to determine their cardiovascular disease risk. The research team tested the new online tool on thousands of American adults and found most adults have a heart that is several years older than their chronological age. Cardiovascular diseases are currently considered the leading cause of death around the world, with about 19.8 million people dying from these types of diseases — such as stroke and heart attack — in 2022. Past studies show that a person's 'heart age' is not always the same as their chronological age. For example, health issues such as high blood pressure, type 2 diabetes, and obesity can raise a person's heart age to be older than their chronological age, putting them at higher risk for cardiovascular disease. In an effort to help people determine their heart's biological age, a team of researchers from Northwestern University Feinberg School of Medicine in Chicago has developed a free online tool to calculate their heart age and determine their cardiovascular disease risk. Additionally, the research team tested the new online tool on thousands of American adults for a study recently published in JAMA Cardiology, and found most adults have a heart that is several years older than their chronological age, sometimes by as much as 10 years. Free online tool helps calculate 'heart age'For this study, researchers first developed the free PREVENT Risk Age Calculator that calculates a person's heart age based on a number of cardiovascular disease risk factors, including their blood pressure and cholesterol levels, smoking history, and whether or not they're on any heart disease-related medications, such as statins or anti-hypertensive the past, heart disease risk has normally been presented as a percentage. This new online tool, researchers say, may provide a 'heart age' calculation that is easier for people to understand. 'We hope this tool helps doctors and patients discuss risk for heart disease more effectively so we can better inform what therapies can prevent heart attacks, stroke, or heart failure events from ever happening,' Sadiya S. Khan, MD, MS, the Magerstadt Professor of Cardiovascular Epidemiology at Northwestern University Feinberg School of Medicine and senior author of this study, says in a press release. Both women and men have higher heart ageResearchers then tested the calculator on more than 14,000 U.S adults between the ages of 30 to 79, who had participated in the National Health and Nutrition Examination Survey between 2011 and 2020. Study participants did not have a cardiovascular disease diagnosis at the time of the survey. Upon analysis, researchers found that on average, women had a heart age of 55.4 and a chronological age of 51.3, while men had a heart age of 56.7 and a chronological age of 49.7. When looking at education as a risk factor, scientists found that about one-third of male participants with a high school or less education had a heart age more than 10 years older than their chronological age. And when examining ethnic groups, researchers found that both Black men and women had the largest gap between their heart and chronological ages. Black men had an average heart age of about 8.5 years more than their chronological age, while the difference between the ages was 6.2 years for Black age indicates heart disease riskMedical News Today had the opportunity to speak with Christina Michael, MD, a cardiologist with Baptist Health Heart & Vascular Care, about this study, who commented that 'heart age' is a clear way to communicate heart risk to patients. 'As a cardiologist, part of my job is helping patients understand their risk of heart disease and empowering them to make changes that can prevent serious problems down the road,' Michael explained. 'Knowing your heart age is important because if your heart age is higher than your actual age, it's a significant wake-up call. This helps us identify individuals who stand to gain the most from interventions.''When patients truly grasp that their heart is 'older' than it should be, it may motivate them to take action. This might mean finally quitting smoking, making healthier food choices, exercising more regularly, or working with their doctor to manage conditions like high cholesterol or high blood pressure.' — Christina Michael, MD'The more precise we can be in identifying who's truly at risk, the better we can tailor our prevention strategies,' Michael added. 'Each new tool helps us identify individuals who will benefit most from aggressive steps to reduce their chances of experiencing a heart attack or stroke. The goal is to get the right interventions to the right people at the right time.'How this tool may help prevent heart diseaseRigved Tadwalkar, MD, FACC, consultative cardiologist and director of Digital Transformation Pacific Heart Institute in Santa Monica, CA, told MNT that this is exactly the kind of tool we've been needing to bridge the gap between clinical data and patient understanding.'Risk percentages can feel abstract,' Tadwalkar explained. 'For example, saying someone has an '8% risk of a cardiovascular event over 10 years' doesn't really land emotionally. But telling someone that their heart is functioning like that of someone 10 or 15 years older resonates much more. It reframes risk in a way that's personal and immediate, which is of high importance when we're trying to prompt lifestyle changes or discuss preventive therapies.' 'From a preventive cardiology standpoint, this is valuable because it gives people a mirror that's calibrated to their health, not just their age,' he continued. 'It helps patients grasp that their risk factors, which often accumulate gradually, are already exerting a physiological toll. And once that reality is more tangible, it opens the door to shared decision-making about how to slow or even reverse that trajectory.' Cheng-Han Chen, MD, a board certified interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in Laguna Hills, CA, agreed. 'Heart disease remains the leading cause of death in the United States. A tidy measure such as 'heart age,' while simplistic, can be a useful tool to frame a discussion around someone's heart health and future risk. This could then motivate them to take actions — such as improving their lifestyles — that could lower their risk. This tool could potentially even be used to evaluate response to clinical therapeutics and interventions.' — Cheng-Han Chen, MD'We are still in the early stages of understanding how best to determine a 'heart age',' he added. 'Much more research is necessary to determine the best measures of such a calculation, and validate its prognostic information.'
